Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa, Multi-center, Multi-national, Open Label, Dose Ranging Study of the Efficacy, Safety, and Tolerability of Oral DU-176b Administered Once or Twice Daily in the Treatment of Adult Patients Undergoing Total Hip Arthroplasty

NCT00107900 is registered in ClinicalTrials.gov with Daiichi Sankyo as lead sponsor.

NCT NCT00107900
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00107900 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa, Multi-center, Multi-national, Open Label, Dose Ranging Study of the Efficacy, Safety, and Tolerability of Oral DU-176b Administered Once or Twice Daily in the Treatment of Adult Patients Undergoing Total Hip Arthroplasty
Lead sponsor
Daiichi Sankyo
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2005
Enrollment
606 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, hip, thrombosis